Colorectal cancer

被引:2853
作者
Brenner, Hermann [1 ,2 ]
Kloor, Matthias [3 ]
Pox, Christian Peter [4 ]
机构
[1] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[2] German Canc Consortium DKTK, Heidelberg, Germany
[3] Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany
[4] Ruhr Univ Bochum, Dept Med, Bochum, Germany
关键词
III COLON-CANCER; ADVANCED RECTAL-CANCER; DOSE-RESPONSE METAANALYSIS; TOTAL MESORECTAL EXCISION; SHORT-COURSE RADIOTHERAPY; OCCULT BLOOD-TEST; MICROSATELLITE INSTABILITY; ADJUVANT THERAPY; LIVER METASTASES; RANDOMIZED-TRIAL;
D O I
10.1016/S0140-6736(13)61649-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
More than 1.2 million patients are diagnosed with colorectal cancer every year, and more than 600 000 die from the disease. Incidence strongly varies globally and is closely linked to elements of a so-called western lifestyle. Incidence is higher in men than women and strongly increases with age; median age at diagnosis is about 70 years in developed countries. Despite strong hereditary components, most cases of colorectal cancer are sporadic and develop slowly over several years through the adenoma-carcinoma sequence. The cornerstones of therapy are surgery, neoadjuvant radiotherapy (for patients with rectal cancer), and adjuvant chemotherapy (for patients with stage III/IV and high-risk stage II colon cancer). 5-year relative survival ranges from greater than 90% in patients with stage I disease to slightly greater than 10% in patients with stage IV disease. Screening has been shown to reduce colorectal cancer incidence and mortality, but organised screening programmes are still to be implemented in most countries.
引用
收藏
页码:1490 / 1502
页数:13
相关论文
共 137 条
[1]   SYNCHRONOUS CARCINOMA OF THE COLON AND RECTUM - PROGNOSTIC AND THERAPEUTIC IMPLICATIONS [J].
ADLOFF, M ;
ARNAUD, JP ;
BERGAMASCHI, R ;
SCHLOEGEL, M .
AMERICAN JOURNAL OF SURGERY, 1989, 157 (03) :299-302
[2]   Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas [J].
Ahlquist, David A. ;
Zou, Hongzhi ;
Domanico, Michael ;
Mahoney, Douglas W. ;
Yab, Tracy C. ;
Taylor, William R. ;
Butz, Malinda L. ;
Thibodeau, Stephen N. ;
Rabeneck, Linda ;
Paszat, Lawrence F. ;
Kinzler, Kenneth W. ;
Vogelstein, Bert ;
Bjerregaard, Niels Chr. ;
Laurberg, Soren ;
Sorensen, Henrik Toft ;
Berger, Barry M. ;
Lidgard, Graham P. .
GASTROENTEROLOGY, 2012, 142 (02) :248-256
[3]   Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis [J].
Al-Sukhni, Eisar ;
Milot, Laurent ;
Fruitman, Mark ;
Beyene, Joseph ;
Victor, J. Charles ;
Schmocker, Selina ;
Brown, Gina ;
McLeod, Robin ;
Kennedy, Erin .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (07) :2212-2223
[4]   Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer A Randomized Trial [J].
Alberts, Steven R. ;
Sargent, Daniel J. ;
Nair, Suresh ;
Mahoney, Michelle R. ;
Mooney, Margaret ;
Thibodeau, Stephen N. ;
Smyrk, Thomas C. ;
Sinicrope, Frank A. ;
Chan, Emily ;
Gill, Sharlene ;
Kahlenberg, Morton S. ;
Shields, Anthony F. ;
Quesenberry, James T. ;
Webb, Thomas A. ;
Farr, Gist H., Jr. ;
Pockaj, Barbara A. ;
Grothey, Axel ;
Goldberg, Richard M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (13) :1383-1393
[5]   Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[6]   Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial [J].
Andre, Thierry ;
Boni, Corrado ;
Navarro, Matilde ;
Tabernero, Josep ;
Hickish, Tamas ;
Topham, Clare ;
Bonetti, Andrea ;
Clingan, Philip ;
Bridgewater, John ;
Rivera, Fernando ;
de Gramont, Aimery .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3109-3116
[7]   Targeted treatments in colorectal cancer: state of the art and future perspectives [J].
Arnold, Dirk ;
Seufferlein, Thomas .
GUT, 2010, 59 (06) :838-858
[8]   Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial [J].
Aschele, Carlo ;
Cionini, Luca ;
Lonardi, Sara ;
Pinto, Carmine ;
Cordio, Stefano ;
Rosati, Gerardo ;
Artale, Salvatore ;
Tagliagambe, Angiolo ;
Ambrosini, Giovanni ;
Rosetti, Paola ;
Bonetti, Andrea ;
Negru, Maria Emanuela ;
Tronconi, Maria Chiara ;
Luppi, Gabriele ;
Silvano, Giovanni ;
Corsi, Domenico Cristiano ;
Bochicchio, Anna Maria ;
Chiaulon, Germana ;
Gallo, Maurizio ;
Boni, Luca .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (20) :2773-2780
[9]   Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies [J].
Aune, D. ;
Lau, R. ;
Chan, D. S. M. ;
Vieira, R. ;
Greenwood, D. C. ;
Kampman, E. ;
Norat, T. .
ANNALS OF ONCOLOGY, 2012, 23 (01) :37-45
[10]   Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies [J].
Aune, Dagfinn ;
Chan, Doris S. M. ;
Lau, Rosa ;
Vieira, Rui ;
Greenwood, Darren C. ;
Kampman, Ellen ;
Norat, Teresa .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 343 :1082